Open science: The open clinical trials data journey

Open data sharing and access has the potential to promote transparency and reproducibility in research, contribute to education and training, and prompt innovative secondary research. Yet, there are many reasons why researchers don’t share their data. These include, among others, time and resource constraints, patient data privacy issues, lack of access to appropriate funding, insufficient recognition of the data originators’ contribution, and the concern that commercial or academic competitors may benefit from analyses based on shared data. Nevertheless, there is a positive interest within and across the research and patient communities to create shared data resources. In this perspective, we will try to highlight the spectrum of “openness” and “data access” that exists at present and highlight the strengths and weakness of current data access platforms, present current examples of data sharing platforms, and propose guidelines to revise current data sharing practices going forward.

[1]  Ana Marusic,et al.  Clinical Trial Registration Looking Back and Moving Ahead , 2007, Annals of Internal Medicine.

[2]  Erik Schultes,et al.  The FAIR Guiding Principles for scientific data management and stewardship , 2016, Scientific Data.

[3]  Bartha M. Knoppers,et al.  Data sharing, year 1--access to data from industry-sponsored clinical trials. , 2014, The New England journal of medicine.

[4]  Harlan M Krumholz,et al.  Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis , 2012, BMJ : British Medical Journal.

[5]  Frank W. Rockhold,et al.  Finding Means to Fulfill the Societal and Academic Imperative for Open Data Access and Sharing , 2018, JAMA cardiology.

[6]  S. Goodman,et al.  Clinical Trial Participants’ Views of the Risks and Benefits of Data Sharing , 2018, The New England journal of medicine.

[7]  Mercè Crosas,et al.  Data Authorship as an Incentive to Data Sharing. , 2017, The New England journal of medicine.

[8]  Zhao-Xiang Bian,et al.  Legislation for trial registration and data transparency , 2010, Trials.

[9]  Francis S. Collins,et al.  Toward a New Era of Trust and Transparency in Clinical Trials. , 2016, JAMA.

[10]  Deepak L. Bhatt,et al.  Availability and Use of Shared Data From Cardiometabolic Clinical Trials , 2017, Circulation.

[11]  John Hoey,et al.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2004, JAMA.

[12]  Frank Rockhold,et al.  Data Sharing at a Crossroads. , 2016, The New England journal of medicine.

[13]  Bradley Malin,et al.  Anonymising and sharing individual patient data , 2015, BMJ : British Medical Journal.

[14]  Nicholas C. Ide,et al.  The ClinicalTrials.gov results database--update and key issues. , 2011, The New England journal of medicine.

[15]  David L DeMets,et al.  Incentives for Clinical Trialists to Share Data. , 2016, The New England journal of medicine.

[16]  C Michael Gibson Moving From Hope to Hard Work in Data Sharing. , 2018, JAMA cardiology.

[17]  J. Menikoff,et al.  The Common Rule, Updated. , 2017, The New England journal of medicine.

[18]  N. Milman,et al.  Tocilizumab increased sustained glucocorticoid-free remission from giant cell arteritis , 2017, Annals of Internal Medicine.

[19]  Bartha M Knoppers,et al.  Data Sharing - Is the Juice Worth the Squeeze? , 2016, The New England journal of medicine.

[20]  Ruben Vicente-Saez,et al.  Open Science now: A systematic literature review for an integrated definition , 2018, Journal of Business Research.

[21]  Data Sharing-The Time Has (Not Yet?) Come. , 2018, JAMA cardiology.

[22]  Mark Barnes,et al.  A Global, Neutral Platform for Sharing Trial Data. , 2016, The New England journal of medicine.

[23]  Michael J. Pencina,et al.  Use of Open Access Platforms for Clinical Trial Data. , 2016, JAMA.

[24]  Fiona Godlee,et al.  [Data sharing statements for clinical trials: a requirement of the International Committee of Medical Journal Editors]. , 2017, Ugeskrift for laeger.

[25]  George A. Mensah,et al.  Use of the National Heart, Lung, and Blood Institute Data Repository , 2017, The New England journal of medicine.

[26]  Cary P Gross,et al.  The importance of clinical trial data sharing: toward more open science. , 2012, Circulation. Cardiovascular quality and outcomes.

[27]  F. Rockhold Statistical controversies in clinical research: data access and sharing-can we be more transparent about clinical research? Let's do what's right for patients. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  Tony Tse,et al.  Trial Reporting in ClinicalTrials.gov - The Final Rule. , 2016, The New England journal of medicine.